Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Amino acid and carnitine supplementation in haemodialysed children

  • 25 Accesses

  • 15 Citations

Abstract

Plasma carnitine, amino acids and lipids levels were studied in ten uraemic children treated with haemodialysis and given amino acid supplementation with and without carnitine. As carnitine is synthesised from lysine and methionine and has a significant influence on lipid metabolism, the relationship between these was examined. Amino acid supplementation (0.25 g/kg body weight) was started with the intention of improving the plasma amino acid pattern in these children and increasing the concentration of lysine, which is the substrate for carnitine synthesis. Amino acids were administered i. v. during dialysis and carnitine (25 mg/kg body weight i. v.) was administered after dialysis three times a week. Concentrations of most essential amino acids were decreased in these patients. The first period of amino acid supplementation did not increase plasma levels of the essential amino acids, with the exception of tyrosine (P<0.01). After the second period of supplementation, methionine was increased (P<0.01), isoleucine was decreased (P<0.01), but tyrosine normalised and was significantly lower than after the first period (P<0.05). Thus overall amino acid supplementation did not improve amino acid levels; it was inconsistently associated with a further decrease in highdensity lipoprotein-cholesterol and an increase in total protein levels. Lysine concentrations after amino acid supplementation remained low. Paradoxically, before carnitine supplementation a positive correlation between free carnitine and triglycerides was observed. The plasma carnitine concentration, initially very low, was excessively high after carnitine supplementation. After carnitine administration no amelioration of any of the other biochemical indices was observed. Carnitine supplementation was associated with a significant reduction of total protein levels (P<0.01). In children with end-stage renal disease on haemodialysis, neither amino acid nor carnitine supplementation appear to result in significant improvements in plasma levels of essential amino acids or lipids.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Bergström J, Alvestrand A, Fürst P (1990) Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 38: 108–114

  2. 2.

    Delaporte C, Jean G, Broyer M (1978) Free plasma and muscle amino acids in uremic children. Am J Clin Nutr 31: 1647–1651

  3. 3.

    Giordano C, Pascale C de, Cristoforo D de, Capodicasa G, Balestrieri C, Baczyk K (1968) Protein malnutrition in the treatment of chronic uremia. In: Berlyne G (ed) Nutrition in renal disease. Churchill Livingstone, Edinburgh, pp 23–32

  4. 4.

    Wolfson M, Jones MR, Kopple JD (1982) Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 11: 500–506

  5. 5.

    Giordano C, Pascale C de, Esposito R, Balestrieri C, Thomson GE, Kaplan D, Friedman EA (1988) Loss of large amounts of amino acids in hemodialysis. Biochem Appl 15: 373–381

  6. 6.

    Alvestrand A, Fürst P, Bergström J (1982) Plasma and muscle free amino acids: influence of nutrition with amino acids. Clin Nephrol 18: 297–305

  7. 7.

    Bulla M, Bremer HJ, Ronda-Vildozola R, Roth B (1986) The effect of oral essential amino acids and their keto-analogues on children receiving regular haemodialysis. Int J Pediatr Nephrol 7: 73–80

  8. 8.

    Heidland A, Kult J (1975) Long-term effect of essential amino acids supplementation in patients on regular dialysis treatment. Clin Nephrol 3: 234–239

  9. 9.

    Guarnieri G, Toigo G, Crapesi L, Situlin R, Del Bianco MA, Corsi M, La Greca P, Paviotti G, Mioni G, Campanacci L (1987) Carnitine metabolism in chronic renal failure. Kidney Int 32: S116-S127

  10. 10.

    Engel AG (1980) Possible causes and effects of carnitine deficiency in man. In: Frenkel RA, McGarry JD (eds) Carnitine biosynthesis, metabolism and function, Academic Press, New York, pp 120–134

  11. 11.

    Gusmano R, Oleggini R, Perfumo F (1981) Plasma carnitine concentrations and dyslipidemia in children on maintenance hemodialysis. J Pediatr 99: 429–432

  12. 12.

    Glöggler A, Bulla M, Fürst P (1989) Effect of low dose supplementation ofl-carnitine on lipid metabolism in hemodialyzed children. Kidney Int 27: S256-S258

  13. 13.

    Armstrong MD, Stave U (1973) A study of plasma free amino acid levels. II. Normal values for children and adults. Metabolism 22: 561–569

  14. 14.

    Pearson DL, Tubbs PK, Chase JFA (1969) Carnitine and acylcarnitine. Methods Enzymol 14: 612–616

  15. 15.

    Boulat O, Jamin B, Francioli P, Bachmann C (1993) Plasma carnitines: reference values in an ambulatory population. Eur J Clin Chem Clin Biochem 31: 585–589

  16. 16.

    Snedecor GW, Cochran WG (1979) Statistical methods. Iowa State University Press, Ames, chapters 10, 11

  17. 17.

    Appel G (1991) Lipid abnormalities in renal disease. Kidney Int 39: 169–183

  18. 18.

    Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD (1990) Multicenter trial ofl-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38: 912–918

Download references

Author information

Correspondence to R. A. M. G. Donckerwolcke.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zachwieja, J., Duran, M., Joles, J.A. et al. Amino acid and carnitine supplementation in haemodialysed children. Pediatr Nephrol 8, 739–743 (1994). https://doi.org/10.1007/BF00869107

Download citation

Key words

  • Carnitine
  • Amino acid supplementation
  • Lipids
  • Uraemic children